Orasure Technologies (OSUR) Other Non-Current Liabilities (2012 - 2025)
Orasure Technologies (OSUR) posted Other Non-Current Liabilities of $9.3 million for Q4 2025, up 28.48% sequentially from $7.3 million in Q3 2025, and down 59.26% YoY from $22.9 million in Q4 2024.
Orasure Technologies (OSUR) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends
Orasure Technologies has reported Other Non-Current Liabilities for 14 years, with the latest figure at $9.3 million in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 59.26% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (down 59.26% YoY) and the FY2025 annual result came in at $9.3 million, down 59.26% from the prior year.
- Other Non-Current Liabilities improved to $9.3 million in Q4 2025 per OSUR's latest filing, from $7.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $23.4 million in Q1 2025 and troughed at $489000.0 in Q2 2022.
- A 5-year average of $5.3 million and a median of $711500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities plunged 75.67% in 2022, then jumped 3809.56% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $651000.0 in 2021, then slipped by 10.75% to $581000.0 in 2022, then advanced by 19.79% to $696000.0 in 2023, then soared by 3191.67% to $22.9 million in 2024, then plunged by 59.26% to $9.3 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $9.3 million, $7.3 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.33 Mn |
| Sep 30, 2025 | 7.26 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | 23.39 Mn |
| Dec 31, 2024 | 22.91 Mn |
| Sep 30, 2024 | 529,000.00 |
| Jun 30, 2024 | 22.91 Mn |
| Mar 31, 2024 | 727,000.00 |
| Dec 31, 2023 | 696,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 586,000.00 |
| Mar 31, 2023 | 609,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 525,000.00 |
| Jun 30, 2022 | 489,000.00 |
| Mar 31, 2022 | 552,000.00 |
| Dec 31, 2021 | 651,000.00 |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.01 Mn |
| Mar 31, 2021 | 2.00 Mn |